PatientsVille.com Logo

PatientsVille

Magne Side Effects

Common Magne Side Effects

The most commonly reported Magne side effects (click to view or check a box to report):

Nephrogenic Systemic Fibrosis (920)
Urticaria (818)
Nausea (602)
Pruritus (564)
Dyspnoea (541)
Vomiting (530)
Erythema (514)
Anxiety (455)
Pain (453)
Joint Range Of Motion Decreased (438)
Oedema Peripheral (393)
Mobility Decreased (371)
Emotional Distress (365)
Arthralgia (343)
Fibrosis (341)
Deformity (266)
Injury (255)
Joint Stiffness (253)
Asthenia (248)
Joint Contracture (240)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Magne Side Effects Reported to FDA

The following Magne reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Magne on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hypoaesthesia, Erythema, Oedema Mouth, Swelling Face
on Mar 10, 2014 Female from US , 36 years of age, was diagnosed with and was treated with Magnevist. Directly after, patient experienced the unwanted or unexpected Magne side effects: hypoaesthesia, erythema, oedema mouth, swelling face. Magnevist dosage: Unk Unk, Once.

Throat Irritation, Paraesthesia Mucosal
Patient was taking Magnevist. Patient felt the following Magne side effects: throat irritation, paraesthesia mucosal on Mar 10, 2014 from US Additional patient health information: Female , 37 years of age, was diagnosed with and. Magnevist dosage: Unk Unk, Once.

Nausea
Adverse event was reported on Mar 06, 2014 by a Female taking Magnevist (Dosage: Unk) was diagnosed with and. Location: US , 56 years of age, After Magne was administered, patient encountered several Magne side effects: nausea.

Vomiting, Sneezing
on Mar 06, 2014 Female from US , 38 years of age, was diagnosed with and was treated with Magnevist. Directly after, patient experienced the unwanted or unexpected Magne side effects: vomiting, sneezing. Magnevist dosage: Unk Unk, Once.


Rash, Vomiting, Nausea
on Mar 05, 2014 Female from US , 31 years of age, was diagnosed with and was treated with Magnevist. Patient felt the following Magne side effects: rash, vomiting, nausea. Magnevist dosage: Unk Unk, Once.

Hypertension
Patient was taking Magnesium (magnesium). After Magne was administered, patient encountered several Magne side effects: hypertension on Jan 15, 2014 from US Additional patient health information: Male , 76 years of age, weighting 183.0 lb, . Magnesium (magnesium) dosage: N/A.
Multiple concurrent drugs taken:
  • Iclusig (ponatinib) Tablet, 15mg
  • Cisplatin (cisplatin)
  • Coreg (carvedilol)
  • Pradaxa (dabigatran Etexilate Mesilate)
  • Nifedical Er (nifedipine)
  • Lovaza (omega-3-acid Ethyl Ester) Capsule


Paraesthesia, Unresponsive To Stimuli
Adverse event was reported on Feb 24, 2014 by a Male taking Magnevist (Dosage: 20 Ml, Once) was diagnosed with and. Location: US , 62 years of age, Directly after, patient experienced the unwanted or unexpected Magne side effects: paraesthesia, unresponsive to stimuli.

Blood Pressure Systolic Increased, Respiratory Rate Increased, Dyspnoea, Wheezing, Eye Pruritus, Cough, Pain
on Feb 06, 2014 Male from US , 23 years of age, weighting 235.9 lb, was diagnosed with and was treated with Magnevist (gadopentetate Dimelumine). Patient felt the following Magne side effects: blood pressure systolic increased, respiratory rate increased, dyspnoea, wheezing, eye pruritus, cough, pain. Magnevist (gadopentetate Dimelumine) dosage: 19 Ml One Time Dose, Iv Via Power Inection. Patient was hospitalized.

Stevens-johnson Syndrome, Oral Mucosa Erosion, Abnormal Sensation In Eye, Erythema, Skin Erosion, Epidermal Necrosis
on Mar 26, 2014 Female from JP , 38 years of age, weighting 114.6 lb, was diagnosed with and was treated with Magnevist. After Magne was administered, patient encountered several Magne side effects: stevens-johnson syndrome, oral mucosa erosion, abnormal sensation in eye, erythema, skin erosion, epidermal necrosis. Magnevist dosage: 10 Ml (1ml/s For About 10 Seconds), Once.

Respiratory Distress, Dizziness, Headache, Urticaria
Patient was taking Magnevist. Directly after, patient experienced the unwanted or unexpected Magne side effects: respiratory distress, dizziness, headache, urticaria on Feb 17, 2014 from VI Additional patient health information: Female , 59 years of age, was diagnosed with and. Magnevist dosage: 17 Ml, Once.

Erythema, Anaphylactic Reaction, Distributive Shock, Slow Response To Stimuli
Adverse event was reported on Jan 29, 2014 by a Female taking Magnevist (Dosage: 14 Ml, Once) was diagnosed with and. Location: JP , 40 years of age, Patient felt the following Magne side effects: erythema, anaphylactic reaction, distributive shock, slow response to stimuli. Patient was hospitalized.

Paraesthesia Mucosal
on Jan 24, 2014 Female from US , 58 years of age, was diagnosed with and was treated with Magnevist. After Magne was administered, patient encountered several Magne side effects: paraesthesia mucosal. Magnevist dosage: 15 Ml, Once.

Urticaria, Pruritus, Contrast Media Reaction
on Jan 24, 2014 Female from US , 31 years of age, was diagnosed with and was treated with Magnevist. Directly after, patient experienced the unwanted or unexpected Magne side effects: urticaria, pruritus, contrast media reaction. Magnevist dosage: 14 Ml, Once.

Tension Headache, Sensation Of Pressure, Anxiety
Patient was taking Magnevist. Patient felt the following Magne side effects: tension headache, sensation of pressure, anxiety on Jan 27, 2014 from US Additional patient health information: Female , 71 years of age, was diagnosed with and. Magnevist dosage: 15 Ml, Unk.

Tension Headache, Intracranial Pressure Increased
Adverse event was reported on Jan 16, 2014 by a Female taking Magnevist (Dosage: 18 Ml, Once) was diagnosed with and. Location: US , 51 years of age, After Magne was administered, patient encountered several Magne side effects: tension headache, intracranial pressure increased.

Pruritus
on Jan 15, 2014 Female from US , 52 years of age, was diagnosed with and was treated with Magnevist. Directly after, patient experienced the unwanted or unexpected Magne side effects: pruritus. Magnevist dosage: Unk Unk, Once.

Toxicity To Various Agents
on Jan 14, 2014 Male from US , 79 years of age, was treated with Magnesium Hydroxide. Patient felt the following Magne side effects: toxicity to various agents. Magnesium Hydroxide dosage: N/A.
Multiple prescriptions taken:
  • Gabapentin
  • Acetaminophen
  • Hydrocodone
  • Ethanol


Pruritus, Flushing
Patient was taking Magnevist. After Magne was administered, patient encountered several Magne side effects: pruritus, flushing on Jan 13, 2014 from US Additional patient health information: Female , 61 years of age, was diagnosed with and. Magnevist dosage: Unk Unk, Once.

Urticaria
Adverse event was reported on Jan 03, 2014 by a Female taking Magnevist (Dosage: 20 Ml, Once) was diagnosed with and. Location: US , 47 years of age, Directly after, patient experienced the unwanted or unexpected Magne side effects: urticaria.

Urticaria
on Jan 02, 2014 Female from US , 57 years of age, was diagnosed with and was treated with Magnevist. Patient felt the following Magne side effects: urticaria. Magnevist dosage: 20 Ml, Once.

Nephrogenic Systemic Fibrosis
on Dec 27, 2013 Female from DK , 59 years of age, was treated with Magnevist. After Magne was administered, patient encountered several Magne side effects: nephrogenic systemic fibrosis. Magnevist dosage: N/A.
Multiple concurrent drugs taken:
  • Omniscan
  • Prednisolone


Phlebitis, Pain, Thrombosis
Patient was taking Magnevistan. Directly after, patient experienced the unwanted or unexpected Magne side effects: phlebitis, pain, thrombosis on Dec 23, 2013 from BR Additional patient health information: Male , 29 years of age, was diagnosed with and. Magnevistan dosage: N/A.

Urticaria
Adverse event was reported on Jan 24, 2014 by a Male taking Magnevist (Dosage: 35 Ml, Once) was diagnosed with and. Location: US , 49 years of age, Patient felt the following Magne side effects: urticaria.

Nephrogenic Systemic Fibrosis, Arthralgia, Musculoskeletal Stiffness, Joint Contracture, Mobility Decreased, Gait Disturbance, Abasia, Skin Discolouration, Joint Stiffness
on Dec 18, 2013 Male from US , 43 years of age, was diagnosed with and was treated with Magnevist. After Magne was administered, patient encountered several Magne side effects: nephrogenic systemic fibrosis, arthralgia, musculoskeletal stiffness, joint contracture, mobility decreased, gait disturbance, abasia, skin discolouration, joint stiffness. Magnevist dosage: 20 Ml, Once.

Anaphylactic Shock, Laryngeal Oedema, Dyspnoea, Cyanosis, Cardio-respiratory Arrest
on Dec 17, 2013 Female from BR , 58 years of age, weighting 183.0 lb, was diagnosed with and was treated with Magnevistan. Directly after, patient experienced the unwanted or unexpected Magne side effects: anaphylactic shock, laryngeal oedema, dyspnoea, cyanosis, cardio-respiratory arrest. Magnevistan dosage: 15 Ml, Once. Patient was hospitalized.

1 of 225 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Magne Side Effects

    Did You Have a Magne Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Magne for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    CHOLINE M CITRATE O CITROMA M GADOPENTE MILK OF M OMEPRAZOL PHILLIPS

    Active Ingredient: ACETAMINO ADENINE; AESCULUS ALMASILAT ALUMINUM AMBERGRIS ANHYDROUS BLACK COH CAUSTICUM CHOLINE M DIMETHICO GADOPENTE LACTIC AC MAGNESIUM OMEPRAZOL

    More About Magne

    Side Effects reported to FDA: 5625

    Magne safety alerts: 2014 2011 2008 2007 2006 2005 2000

    Reported deaths: 474

    Reported hospitalizations: 648

    Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use

    Prescription PPIs include Nexium (esomeprazole magnesium), Dexilant (dexlansoprazole), Prilosec (omeprazole), Zegerid (omeprazole and sodium bicarbonate), Prevacid (lansoprazole), Protonix (pantoprazole sodium), AcipHex (rabeprazole sodium), and Vimovo (a prescription combination drug product that contains a PPI (esomeprazole magnesium and naproxen).

    Over-the-counter (OTC) PPIs include Prilosec OTC (omeprazole), Zegerid OTC (omeprazole and sodium bicarbonate), and Prevacid 24HR (lansoprazole).

     

    [Posted 03/02/2011]

    AUDIENCE: Consumer, Gastroenterology, Family Practice

    ISSUE: FDA notified healthcare professionals and the public that prescription proton pump inhibitor (PPI) drugs may cause low serum magnesium levels (hypomagnesemia) if taken for prolonged periods of time (in most cases, longer than one year). Low serum magnesium levels can result in serious adverse events including muscle spasm (tetany), irregular heartbeat (arrhythmias), and convulsions (seizures); however, patients do not always have these symptoms. Treatment of hypomagnesemia generally requires magnesium supplements. In approximately one-quarter of the cases reviewed, magnesium supplementation alone did not improve low serum magnesium levels and the PPI had to be discontinued.

    BACKGROUND: PPIs work by reducing the amount of acid in the stomach and are used to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus.

    RECOMMENDATION: Healthcare professionals should consider obtaining serum magnesium levels prior to initiation of prescription PPI treatment in patients expected to be on these drugs for long periods of time, as well as patients who take PPIs with medications such as digoxin, diuretics or drugs that may cause hypomagnesemia. For patients taking digoxin, a heart medicine, this is especially important because low magnesium can increase the likelihood of serious side effects. Healthcare professionals should consider obtaining magnesium levels periodically in these patients. For additional information, refer to the Data Summary section of the FDA Drug Safety Communication.

    Healthcare professionals and patients are encouraged to report adverse events, side effects, or product quality problems related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [03/02/2011 - Drug Safety Communication - FDA]

    Latest Magne clinical trials